Pictet Alternative Advisors has announced the close of its first healthcare-focused thematic private equity fund at $320m – exceeding its target size of $300m.
The fund was launched in 2022 and is managed by Yann Mauron, David Braga Malta and Chiara Brambillasca.
It invests in five segments: therapeutics, diagnostics, digital health, medical technology, and healthcare providers and service providers.
The fund has already started committing capital to biotech and healthcare-focused VC, growth and buyout funds and will dedicate a substantial allocation to co-investments.
Pictet has now raised a total of $950m across its thematic private equity franchise, from a mixture of high-net-worth and institutional investors.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Pictet 2022 Fund Launch –
Pictet’s alternative investment unit, Pictet Alternative Advisors, has launched a private equity fund focusing on the healthcare sector.
It invests in venture capital in the biotech and healthcare sectors and focuses on five segments: therapeutics, diagnostics, digital health, medical technology, and healthcare providers and service providers.
Yann Mauron is the investment manager of the strategy. He said: ‘Health is a high priority for society as a whole. We are at a tipping point for breakthroughs in medicine: investment is increasing, regulation is providing more support, and technology offers more potential solutions.
‘As recent vaccination successes show, we live in promising times for the healthcare sector. What science would have normally taken 10 years to do was achieved in less than a year.’
Source: Citywire
Can’t stop reading? Read more
UBS sells $11bn O’Connor platform to Cantor Fitzgerald in major hedge fund reshuffle
UBS sells $11bn O’Connor platform to Cantor Fitzgerald in major hedge fund reshuffle Cantor...
TPG and Blackstone offer $16bn to take Hologic private in major healthcare bid
TPG and Blackstone offer $16bn to take Hologic private in major healthcare bid TPG and Blackstone...
Eurazeo targets GovTech expansion with majority stake in 3P
Eurazeo targets GovTech expansion with majority stake in 3P Eurazeo has entered exclusive...